A refrigeration preservation solution suitable for epithelial, endothelial, and neural tissues that does not contain DMSO or serum proteins.
"Stem Cell Keep" is a vitrification freezing preservation solution optimized to maintain high vitrification ability while minimizing cytotoxicity, specifically designed for primate ES/iPS cells. Thanks to the high cell protection effect of a novel cryoprotectant with high safety and the ability to maintain a glassy state, it has become possible to freeze and preserve ES/iPS cell colonies more efficiently. 【Features】 ■ Contains no DMSO or animal protein components ■ Allows for freezing preservation of colonies using the vitrification method ■ Can preserve stem cell differentiation ability during freezing ■ Confirmed to be free from contamination by bacteria, fungi, and mycoplasma through sterility testing ■ Can be stored stably at 4°C for an extended period (shelf life of 2 years) *For more details, please refer to the related links or feel free to contact us.
Inquire About This Product
basic information
For more details, please see the related links or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the related links or feel free to contact us.
Company information
BMG is a research and development venture company that has been challenging the development of new biomaterial products adapted to trends in the medical field, based on a long-standing strong collaboration with the Kyoto University Institute for Advanced Medical Research. Focusing on the field of medical polymers (macromolecules), we are engaged in two promising growth businesses: the "BioDegmer" business and the new products business, as well as research and development aimed at providing innovative solutions in the medical field. Under the management philosophy of "contributing to the health of people around the world by working on the development of better biomaterial products and providing innovative solutions in the medical field," we support the improvement of technologies in the next generation of regenerative medicine and the healthy well-being of people in three areas.
